Tartrazine (CI 19140), 25 g, glass packaging

2-Ureidosuccinic acid, 95.0%, 5g

5-Benzyl-2-(4-fluoro-phenyl)-4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine, 95.0%, 1g

Triethoxsilylbutyraldehyde, 90%, 10g

4-Bromo-2-chloro-benzoic acid ethyl ester, 95.0%, 250mg

Dipropylene glycol dimethyl ether, min 99%, for synthesis, 5L, plastic packaging.

2-(3-(Methoxymethoxy)naphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 500mg

6-Pyrrolidin-1-yl-nicotinic acid, 95.0%, 5g

3-Chloro-4-ethynylbenzoic acid, 97.0%, 250mg

(4-(Benzyl(methyl)carbamoyl)phenyl)boronic acid, 95.0%, 25g

2-(2,5-DIFLUOROPHENOXY)ACETIC ACID, 95.0%, 1g

2-(5-Chloro-2-thienyl)pyridine, 97.0%, 2g

2-Chloro-5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 1g